Jan06Wed
Jan06Wed
Exit interview: Dan Hilferty reflects on 10 years at the helm of Independence Blue Cross
John George, Philadelphia Business Journal
After 10 years at the helm of the region’s largest health insurance company, Dan Hilferty stepped down as CEO of Independence Health Group on Jan. 1 and handed off the top post at Independence Blue Cross’ parent company to former CFO Gregory Deavens. In a wide-ranging interview with the Philadelphia Business Journal during his final days on the job, Hilferty talked about health care reform, industry consolidation, Covid-19, mental health care, and more.
Click HERE to read more.
Jan05Tue
Irish pharma group ICON plc carried out trial of Pfizer-BioNTech vaccine
The Irish Times
The trial, involving 44,000 participants, was largest trial of a Covid-19 vaccine
Irish clinical trials group Icon has revealed that it carried out the late-stage trial of the Pfizer-BioNTech coronavirus vaccine.
The trial, which involved 44,000 participants over a four-month period last year, was the largest trial of a Covid-19 vaccine.
Pfizer and BioNTech were the first to announce positive efficacy results from a late-stage study, and the first to receive authorisation for deployment.
Kerry distillery to invest €4m in business this year
The Irish Times
Skellig Six18 ramps up operations as it continues to raise funds for the business
Skellig Six18, which is developing a €10 million micro-distillery and visitor centre along the Ring of Kerry, is expecting to invest about €4 million in the business this year.
Jan04Mon
Dec30Wed
